- Home
- / Sino Biopharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Sino Biopharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.5
2024-10-29
Market Capitalization
$63.5 B
2024-10-29
Revenue
¥31.8 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 20.9B | 24.2B | 23.6B | 26.9B | 28.8B | 28.0B | 28.9B | 31.8B |
| Cost of goods sold | 3.0B | 3.5B | 3.5B | 4.3B | 4.7B | 4.0B | 4.0B | 4.5B |
| Gross profit | 18.1B | 21.1B | 20.4B | 22.8B | 24.3B | 24.6B | 25.3B | 27.6B |
| Gross profit margin, % | 86.9% | 86.9% | 86.2% | 84.8% | 84.4% | 87.7% | 87.4% | 86.7% |
| Operating expense total | 12.6B | 14.3B | 14.3B | 17.3B | 17.1B | 17.2B | 18.1B | 19.5B |
| Depreciation and amortization | 1.2B | 1.4B | 1.7B | 992.6M | 1.1B | 1.0B | 1.6B | 1.3B |
| EBITDA | 5.6B | 6.9B | 6.1B | 19.1B | 7.0B | 6.8B | 7.0B | 8.0B |
| EBITDA margin, % | 26.8% | 28.4% | 25.7% | 70.9% | 24.4% | 24.2% | 24.4% | 25.1% |
| EBIT | 11.0B | 5.4B | 4.4B | 18.1B | 6.1B | 5.7B | 6.6B | 6.7B |
| EBIT margin, % | 52.7% | 22.4% | 18.8% | 67.2% | 21.3% | 20.4% | 23.0% | 21.1% |
| Interest income | 162.7M | 257.7M | 194.0M | 162.1M | 201.4M | 186.7M | 499.6M | 633.6M |
| Interest expense | 153.3M | 230.0M | 323.4M | 308.6M | 439.1M | 511.1M | 295.1M | 278.3M |
| Pre tax profit | 11.4B | 5.7B | 5.0B | 18.6B | 5.8B | 5.7B | 7.0B | 6.9B |
| Income tax expense | 696.2M | 902.7M | 672.4M | 2.0B | 776.0M | 836.2M | 629.7M | 1.6B |
| Net Income | 10.7B | 4.8B | 4.3B | 16.6B | 5.0B | 4.9B | 6.4B | 5.3B |